C M Bidwell & Associates LTD Sarepta Therapeutics, Inc. Transaction History

C M Bidwell & Associates LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$93.7 - $141.53 $145,141 - $219,229	-1,549 Reduced 99.74%	4 $0
Q3 2023 Nov 13, 2023	SELL	$102.5 - $123.59 $2,870 - $3,460	-28 Reduced 1.77%	1,553 $188,000
Q1 2023 May 11, 2023	SELL	$117.53 - $155.99 $11,400 - $15,131	-97 Reduced 5.78%	1,581 $217,000
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $80,101 - $126,155	1,058 Added 170.65%	1,678 $185,000
Q2 2022 Aug 12, 2022	BUY	$62.69 - $88.44 $36,987 - $52,179	590 Added 1966.67%	620 $46,000
Q1 2022 Apr 29, 2022	SELL	$63.15 - $90.42 $101,987 - $146,028	-1,615 Reduced 98.18%	30 $2,000
Q4 2021 Feb 11, 2022	BUY	$77.28 - $99.42 $127,125 - $163,545	1,645 New	1,645 $148,000

528

85M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.79B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.